The nitrogenous -acceptor ligand 4-cyanopyridine (4CNPy) exhibits reversible ligation to ferrous heme in the flavocytochrome P450 BM3 (K d ‫؍‬ 1.8 M for wild type P450 BM3) via its pyridine ring nitrogen. The reduced P450 -4CNPy adduct displays unusual spectral properties that provide a useful spectroscopic handle to probe particular aspects of this P450. 4CNPy is competitively displaced upon substrate binding, allowing a convenient route to the determination of substrate dissociation constants for ferrous P450 highlighting an increase in P450 substrate affinity on heme reduction. For wild type P450 BM3, K d (red)(laurate) ‫؍‬ 82.4 M (cf. K d (ox) ‫؍‬ 364 M). In addition, an unusual spectral feature in the red region of the absorption spectrum of the reduced P450 -4CNPy adduct is observed that can be assigned as a metal-to-ligand charge transfer (MLCT). It was discovered that the energy of this MLCT varies linearly with respect to the P450 heme reduction potential. By studying the energy of this MLCT for a series of BM3 active site mutants with differing reduction potential (E m ), the relationship E MLCT ‫؍‬ (3.53 ؋ E m ) ؉ 17,005 cm ؊1 was derived. The use of this ligand thus provides a quick and accurate method for predicting the heme reduction potentials of a series of P450 BM3 mutations using visible spectroscopy, without the requirement for redox potentiometry.
Cytochromes P450 are monooxygenases found within every domain of life from Archaea to mammals. They catalyze the activation and insertion of an atom of oxygen (derived from molecular oxygen) into a wide array of organic substrates (1, 2) from small molecules such as nitric oxide (P450nor) to larger molecules such as cholesterol (P450scc). They are often essential for many important metabolic, catabolic, and biosynthetic processes in vivo (3) , and as a result have been the subject of a great deal of research.
The name P450 derives from the characteristic Soret absorption spectrum of the ferrous-CO adduct that occurs at 450 nm (4, 5) , hence "Pigment-450." Since this initial observation, UVvisible spectroscopy has become the primary and most intensively exploited spectroscopic technique for the study of such hemoproteins. Spectral shifts associated with changes in redox state (6, 7) and the binding of substrates and other exogenous ligands (8 -10) can provide an enormous wealth of mechanistic data, which provides a useful basis for further study using other specialized and complementary techniques such as EPR, resonance Raman, and magnetic circular dichroism.
Studies have suggested that the affinity of a P450 enzyme for substrate is dramatically increased on reduction (11, 12) . According to the Gibbs free energy relation, the shift in reduction potential upon substrate binding (⌬E m ) is related to the substrate dissociation constants (K d ) of the two redox states of the enzyme, i.e. ϪRTln(K d (ox)/K d (red)) ϭ ϪnF⌬E m . This implies that the positive shift in the heme reduction potential often associated with substrate binding is directly linked, through concomitant changes in the Gibbs free energy, with tighter substrate binding to the ferrous forms of these enzymes. A simple schematic showing the relative changes in the free energies (⌬G) on substrate binding and reduction is shown in Fig. 1 .
Such an increase in affinity may be important for the reaction in terms of efficient coupling by positioning the substrate in preparation for subsequent steps of the catalytic cycle (11, 12) . However, substrate dissociation constants are difficult to quantify for the ferrous form of cytochromes P450. The method by which dissociation constants are determined for the ferric state relies on the spectral shifts associated with the low spin (419 nm) to high spin (390 nm) conversion of the heme iron induced upon addition of substrate. Binding of substrate to P450s displaces a weakly ligated water ligand that occupies the sixth coordination site of the heme iron, hence the iron geometry changes from octahedral (low spin, S ϭ 1/2) to squarebased pyramidal (high spin, S ϭ 5/2) (8, 11) . Unfortunately, determination of the substrate dissociation constant for the reduced form, K d (red), cannot be measured in an analogous fashion to the oxidized form, as the substrate-free and substrate-bound ferrous complexes are both high spin and hence exhibit indistinguishable absorption spectra (A max ϭ 410 nm) (13, 15) . There are several techniques available that allow us to calculate ferrous P450 dissociation constants such as isothermal titration calorimetry and potentiometry (using ϪRTln(K-
However, these techniques offer their own problems, and neither is as straight forward as a simple substrate titration.
Catalytic regulation of cytochromes P450 is critical in order to prevent the uncoupled oxidation of NADPH. One way in which this regulation is achieved is through substrate binding, an event that controls electron transfer by a combination of kinetic and thermodynamic processes associated with the heme iron. In P450 BM3, the binding of substrate kinetically controls electron transfer by decreasing the reorganization energy of reduction, while simultaneously shifting the midpoint potential of the heme to more positive, thus exerting thermodynamic control (14) . Knowledge of P450 heme reduction potentials is central to understanding the P450 mechanism and yet is experimentally complicated to determine for several reasons. The inherent reactivity of P450 heme with molecular oxygen means that potentiometry has to be performed in strictly anaerobic conditions, often requiring the use of sophisticated cells or glove boxes (6, 7, 23) . The technique also requires soluble protein of high concentration and the use of mediators to achieve efficient electrical communication with the electrode, also equilibration periods are often long and solutions require continual stirring. All these factors lead to difficulties in easily calculating heme reduction potentials. A simple spectroscopic method for approximately estimating the midpoint potential for a series of hemoproteins, such as the P450 BM3 wild type and mutant enzymes reported in this paper, would be of considerable interest.
This paper reports the development of two assays, involving the use of a heme ligand, 4-cyanopyridine, which provides a route to the quick and easy determination of substrate dissociation constants for reduced P450 BM3, and presents a means of estimating heme reduction potentials across a series of closely related BM3 mutants without the requirement for redox potentiometry.
EXPERIMENTAL PROCEDURES
Protein Preparation-Heme domain proteins of P450 BM3 (wild type, F393H, F393W, F393A, and F393Y) were overexpressed and purified from Escherichia coli strain TG1 as described previously (9, 14) . All P450 BM3 enzymes were extracted and purified according to the established protocol (16) . Purified samples were flash-frozen in liquid nitrogen prior to storage at Ϫ80°C and were used within 6 months of manufacture.
Purification of 4-Cyanopyridine-Crude 4-cyanopyridine (4CNPy) 1 was purchased from Sigma (ϳ 80% purity) and was purified by vacuum sublimation onto a cold finger. Purified 4CNPy was stored in a dessicator at room temperature and used within 1 month of sublimation. The use of crude 4CNPy must be avoided because it contains a significant amount of free cyanide, which ligates tightly and preferentially to P450 in both oxidation states. Vacuum sublimation generates sufficiently pure 4CNPy (spectrum of ferrous P450 -4CNPy has no trace of ferrous P450-CN) for the purpose of these experiments. The aqueous 4CNPy stocks were prepared by using assay buffer (20 mM MOPS, 100 mM KCl, pH 7.4). Fresh stocks ([4CNPy] ϭ 180 mM) were used for each experiment.
Ligand Binding Titrations-The dissociation constants for 4CNPy with wild-type P450 BM3 and the mutant enzymes F393H and F393W were determined by titrating small aliquots of aqueous 4CNPy (180 mM stock) into samples of either oxidized or reduced protein (ϳ5 M) (25°C in 20 mM MOPS, 100 mM KCl, pH 7.4). The resultant visible absorption spectra were recorded after each addition. Difference spectra were generated by subtraction of the absolute oxidized (or reduced) protein spectrum from each 4CNPy-bound spectrum. Dissociation constants were calculated by plotting the maximum absorbance change in the difference spectra versus [4CNPy] and evaluated by fitting the data to a rectangular hyperbola (Microcal Origin). Titrations involving oxidized enzymes were performed on a Shimadzu 1601 spectrophotometer on the bench. All 4CNPy titrations of reduced P450s were performed in an anaerobic environment (Belle Technology Glove box) with the oxygen concentration maintained at Ͻ5 ppm, using a Varian Cary 50 UV-visible spectrophotometer. Enzyme samples were reduced in the anaerobic box by the addition of a few grains of solid sodium dithionite immediately prior to the titration. Excess dithionite was removed by elution through a pre-equilibrated G-25 gel filtration column.
Fatty Acid Binding Titration-Dissociation constants for fatty acid (laurate and arachidonate) binding to ferric wild-type P450 BM3 and the mutant enzymes F393H and F393W have been determined and reported in previous publications (9, 14) (25°C in 20 mM MOPS, 100 mM KCl, pH 7.4). However, to ensure that K d (red) and ⌬E m values determined via the 4CNPy and OTTLE methods were directly comparable, the dissociation constants for laurate with P450 BM3 in high salt OTTLE potentiometry buffer (100 mM Tris, 500 mM KCl, pH 7.50) were calculated. Substrate dissociation constants were determined essentially as described for 4CNPy. Small aliquots (25-100 l) of the P450 BM3 enzyme solution were removed from the reaction mixture (ϳ6 M 
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enzyme in OTTLE/assay buffer) and replaced with corresponding aliquots from an identical solution containing 1 mM laurate. The resulting changes in the absorption spectra associated with the substrate-induced spin state shift were recorded after each addition using a Shimadzu 1601 spectrophotometer. Dissociation constants were calculated by plotting the maximum absorbance changes in the difference spectra against substrate concentration and fitting to a rectangular hyperbola (Microcal Origin).
Competitive Ligand Binding Studies-To evaluate the dissociation constant for ferric BM3 with substrate, 4CNPy titrations were carried out in the presence of varying concentrations of laurate (25°C in 20 mM MOPS, 100 mM KCl, pH 7.4; wt K d (ox) ϭ 364 M; [laurate] used was ϳ20, 40, 60, 80, 120, and 160 M). The apparent dissociation constants (K d app ) were evaluated and plotted against the corresponding laurate concentrations. The inhibitor constant (K d (red)) was evaluated as the intercept/gradient. Titration of 4CNPy into substrate-bound, ferrous P450 competitively displaces the substrate as it ligates the heme. The substrate laurate was chosen for these studies as its K d value for the oxidized protein (ϳ400 M) was found to be sufficient to be displaced by a modest concentration of 4CNPy. Substrates that exhibited significantly lower K d values for the oxidized enzyme (arachidonate, K d (ox) ϭ 3.6 M (9)) bound too tightly in comparison to 4CNPy and did not display double-reciprocal plots indicative of competitive inhibition.
OTTLE Potentiometry-According to the equations, ⌬G ϭ ϪnFE and ⌬G ϭ ϪRTlnK, a correlation exists between the change in binding constant on reduction and the change in potential on substrate binding (ϪnF⌬E ϭ ϪRTln(
. If the dissociation constant of the oxidized form of the enzyme and the substrate-induced potential shift are both known, then this relationship allows the evaluation of the dissociation constant for the reduced form. Consequently, the evaluation of the substrate-induced potential shift provides us with a useful tool to measure the suitability of the 4CNPy technique in calculating K d (red) values. Heme reduction potentials for wild type BM3 and the mutant enzymes F393H and F393W in the absence of substrate have been determined and reported previously (9, 14) . To provide a comparison to the 4CNPy competitive binding experiments, OTTLE potentiometry was used to resolve the heme reduction potentials of the laurate-saturated (ϳ1 mM) form of the enzymes. A specially constructed cell comprised of a modified quartz EPR cell with a path length of 0.3 mm, Pt/Rh (95/5) gauze working electrode (wire diameter 0.06 mm, mesh size 1024 cm Ϫ1 , Engelhardt, UK), platinum wire counter electrode, and a Ag/AgCl reference electrode (model MF2052, Bioanalytical Systems, IN 47906) was used. Enzyme samples (1 ml ϳ100 M) were dialyzed into 100 mM Tris, 500 mM KCl, pH 7.50, saturated with laurate (1 mM), and allowed to equilibrate in an anaerobic glove box overnight. The following range of mediators was added to ensure efficient reduction and reoxidation: 2-hydroxy-1,4-naphthaquinone, FMN, benzyl viologen, and methyl viologen. OTTLE potentiometric titrations were carried out according to a protocol reported previously (14) . Maximum absorbance changes associated with a change in the redox state were plotted against applied potential (versus standard hydrogen electrode), and E m values were determined by fitting the data to the Nernst equation (Microcal Origin). All potentials were corrected relative to standard hydrogen electrode by ϩ195 mV to account for the Ag/AgCl electrode.
Energy of MLCT-The energies of the metal to ligand charge transfer band were determined for wild type P450 BM3 and the mutant enzymes F393H, F393W, F393Y, and F393A. Enzyme samples were pre-reduced with sodium dithionite prior to the addition of saturating concentrations of 4CNPy. Absorption spectra were recorded before and after addition of the ligand. The appearance of a peak at 630 -650 nm in the 4CNPy-saturated spectra was ascribed as a MLCT band. The energy of the MLCT was calculated from the wavelength of the resulting peak using the equation E MLCT ϭ 1/ MLCT . 

RESULTS
4-
Cyanopyridine-Visible spectra of the P450 ox -4CNPy complexes are essentially the same as their respective ligand-free, ferric forms (Fig. 2) . Conversely, the reduced complex exhibits a significant change in the Soret absorption from 419 nm (P450 ox -4CNPy) 3 440 nm (P450 red -4CNPy). Similar shifts were observed for P450 BM3 to those observed for pyridine binding to P450cam (21) , indicating the same binding mode for 4CNPy via the pyridine nitrogen. Two noteworthy observations obtained from the ligand titrations, not seen when pyridine was used as the ligand, are as follows: first, the formation of a new absorption band (Fig. 2) assigned as the metal-to-ligand charge transfer (MLCT) Fe(II) 3 *4CNPy (4CNPy is a good -acid with low lying * anti-bonding orbitals (17, 24) in the red region of the spectrum (A max ϭ 620 -670 nm)); and second, an increase in the affinity of 4CNPy for ferrous P450 (Table I) in comparison to the ferric form. The affinity of 4CNPy for reduced heme is ϳ2-3 orders of magnitude greater than for oxidized heme, and this has implications for the competitive binding studies which will be discussed in detail later.
Laurate Binding-The dissociation constants calculated for laurate with P450 BM3 in high salt OTTLE buffer were found to be in good correlation with the dissociation constants obtained in the standard assay buffer used for 4CNPy competitive binding studies. The dissociation constants quoted in Table II correspond to the values determined in high salt (100 mM Tris, 500 mM KCl, pH 7.5) buffer. As the K d (ox) values do not significantly change in the presence of higher concentrations of salt, a direct comparison can be made between the dissociation constants and substrate-induced potential shift calculated through the 4CNPy assay and the OTTLE technique (i.e. a comparison of K d (red) and estimated ⌬E m (4CNPy assay) with the calculated ⌬E m and estimated K d (red) (OTTLE)).
Competitive Binding between 4CNPy and Laurate-The ferrous form of P450 BM3 and its active site mutants displayed competitive ligation between 4CNPy and laurate, allowing the K d value for laurate with the ferrous form of the enzyme (K d (red)) to be measured. In all cases, the apparent dissociation constant for 4CNPy (K d app ) increased with increasing substrate concentration. In this respect, substrate can be considered as acting as an inhibitor of 4CNPy ligation (in this context, substrate will be referred to as the "competitor" of 4CNPy binding). Fig. 3 . The convergence of the double-reciprocal plots on the y axis confirms the nature of the inhibition to be competitive. By plotting K d app versus substrate concentration, a linear relationship was observed (Fig. 4) 
FIG. 5. OTTLE potentiometry for laurate-saturated cytochrome P450 BM3 wild type, F393H, and F393W.
A shows the fully oxidized and fully reduced spectra of wild type P450 BM3. Note the mix spin nature of the oxidized, substrate-bound species exhibiting a peak at 420 nm (low spin) and shoulder at 390 nm (high spin). Also note the relatively large change in absorbance around 450 -460 nm. B shows the normalized ⌬A at 455 nm values plotted against the applied potential and the 1 electron Nernst function fit used to evaluate the mid-point reduction potential for each of the enzymes studied (wild type (•), F393H (OE), and F393W (f)).
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OTTLE Potentiometric Titrations-To verify the applicability of the 4CNPy technique in calculating K d (red) and hence ⌬E m , OTTLE potentiometry was used to determine the ⌬E m for BM3 thus providing another route to the evaluation of K d (red). Since ⌬E m is the difference in the substrate-free and substratebound heme reduction potentials, this necessitated the calculation of the laurate-saturated mid-point potential. Fig. 5A shows the spectral shifts observed during the potentiometric titration of wild type BM3 containing saturating concentrations of laurate. For wild type BM3 and the mutant enzymes F393H and F393W, saturating concentrations of laurate lead to a mixed spin enzyme (ϳ35% high spin), a factor that can be seen clearly in the oxidized spectra. Fig. 5B shows the absorbance changes at 455 nm plotted against the measured potential (versus standard hydrogen electrode) in conjunction with the one-electron Nernst function fit for each of the enzymes studied. The calculated laurate-saturated E m values (Table II) in conjunction with the previously determined substrate-free values generated ⌬E m values of ϩ89, ϩ84, and ϩ91 mV for wild type, F393H, and F393W, respectively. It is clear that whereas wild type and the point mutations, F393H and F393W, have significantly different substrate-free reduction potentials (Table II), the magnitude of the substrate-induced potential shift remains constant. The importance of these figures as a comparison to the 4CNPy assay will be discussed in detail later.
Prediction of P450 Heme Reduction Potentials-The position of the new MLCT absorption generated upon ligation of 4CNPy to ferrous heme was observed to vary with the proteins studied (Fig. 6A) . The wavelength of this absorption band for the P450s studied is shown in Table II alongside their respective reduction potentials. A linear relationship is observed between the energy of the absorption band and the heme reduction potential (E MLCT ϭ (3.53 ϫ E m ) ϩ 17,005 cm Ϫ1 , Fig. 4B ), indicating that the origin of the absorption is sensitive to the redox nature of the heme iron in keeping with the band assignment to MLCT.
DISCUSSION
The two features of 4-cyanopyridine that make it an ideal ligand for the type of studies outlined in this paper are as follows: first, its selective and tight reversible binding to ferrous heme (with little affinity for ferric heme), and second, the unusual spectral properties of the 4CNPy-ferrous heme adduct. The methodology outlined for the determination of substrate dissociation constants for reduced P450 exploits these observations. The specificity of 4CNPy for reduced P450 allows the evaluation of substrate dissociation constants for purely the reduced enzyme and eliminates interference from binding of 4CNPy/substrate to ferric heme.
An increase in substrate binding affinity upon heme reduction is inferred by the potential difference between the reduction potentials of the substrate-free and substrate-bound forms of cytochromes P450 (11) . Introduction of substrate into the active site increases the heme reduction potential, typically by ϳ100 -150 mV depending on the nature of the substrate, thus thermodynamically controlling electron transfer from the reductase (6) (⌬G ϭ ϪnFE). Consideration of the Gibbs free energy relation (⌬G ϭ ϪRTlnK) suggests that this increase in reduction potential must be because of a decrease in the magnitude of the equilibrium constant, K in this case; K can be considered as the ratio of the substrate dissociation constants
. Theoretically, K d should decrease upon protein reduction. It is widely accepted that there is considerable peptide motion upon substrate binding to P450 BM3, associated with dehydration of the active site (18, 19) . A similar conformational contraction may be expected upon reduction, to bring the substrate closer to the heme to facilitate oxygenation. This is substantiated by NMR relaxation experiments, which show a dramatic 6-Å movement of the substrate toward the heme upon reduction (12) . In addition, a recent study by Morishima and co-workers. (29) shows that complexation of P450cam with its electron transfer partner, putidaredoxin, causes significant conformational changes in the active site. These types of active site contractions probably serve a variety of purposes as follows: to ensure dehydration of the active site, improve coupling (3, 25) , and also to stabilize the Michaelis complex. Analysis of the palmitoylate-bound crystal structure of P450 BM3 supports this (20) , because in the oxidized form, the terminus of the substrate is too far from the heme (ϳ8 Å) to allow oxygenation, thus invoking an argument to support some movement of the substrate prior to hydroxylation.
The magnitude of the substrate binding constants for the ferrous P450s (K d (red)) calculated by both the 4CNPy technique and through OTTLE measurements are considerably lower than those determined for the ferric enzymes as predicted. These measurements help quantify the degree to which substrate is bound tighter to the active site in the catalytically relevant, ferrous form of the enzymes. Substrate binding constants can be used to determine the Gibbs free energy (⌬G) of substrate binding to ferric and ferrous P450 by using the equation ⌬G ϭ ϪRTlnK d . The difference between these calculated 
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values gives an indication of the relative stabilities of the ferric substrate-bound P450 compared with the ferrous substratebound P450. Clearly, the ⌬G value for the ferrous complex will be greater than that for the ferric complex indicating a more stable (lower in energy) reduced species. In addition, we can hypothesize that as the K d (ox) for wild type BM3 with arachidonate is lower than that observed for laurate, it will likely have a similarly smaller K d (red). Therefore, it follows that ⌬G(red) values observed using the substrate arachidonate (Ͼ90% substrate-induced potential shift) would be of a greater magnitude than for laurate (ϳ35% substrate-induced potential shift). This suggests that more stable ferrous complexes are formed with more appropriate substrates.
As mentioned previously, by using the equation Table III shows the comparison of these calculated values for wild type P450 BM3 and the mutant enzymes F393H and F393W. It can be seen that the values are of a similar magnitude although they do not correlate exactly. The use of the 4CNPy assay correctly predicts an increase in substrate affinity on heme reduction and subsequently an increase in the heme reduction potential, which highlights the applicability of the 4CNPy competitive titration in predicting K d (red). It is obvious, however, that the two sets of data do not match exactly and that there is a discrepancy between the two techniques. This can be illustrated in the case of wild type P450 BM3 with laurate (⌬E m (4CNPy) ϭ ϩ38 mV, ⌬E m (OTTLE) ϭ ϩ89 mV, K d (red)(4CNPy) ϭ 82.4 M, and K d (red)(OTTLE) ϭ 11.3 M). The difference in the predicted and measured values is likely to be a consequence of the nature of the competition between ligand and substrate. In P450 BM3, substrate binding occurs at the mouth of the active site where two residues, Tyr-51 and Arg-47 (30) form a H-bond and salt bridge with the substrate carboxylate head. The consequence of this is that the binding of substrate is not directly influenced by the binding of 4CNPy to the iron, although there is competition between the substrate tail and 4CNPy. As a result, it is unlikely that laurate and 4CNPy display pure competition, a factor that may lead to the overestimation of the K d (red)(4CNPy).
It has also been demonstrated that 4-cyanopyridine can be exploited to predict the substrate-free P450 heme reduction potentials. This feature makes 4-cyanopyridine a fundamentally important mechanistic probe. The energy of the MLCT absorption upon formation of the 4CNPy-ferrous adduct varies linearly with heme reduction potential. Similar observations have been noted in studying the correlation of absorption band energy of simple inorganic complexes with reduction potential (26 -28) . However, the previous correlations have been reported for MLCT energies and metal-based redox potentials of the same compounds. In this study the linear relationship exists between the MLCT (Fe(II) 3 4CNPy) band maximum and the Fe(III/II)-based couple of the substrate-free heme. The experimental observation of a linear relationship between the MLCT band position of the 4CNPy-bound heme and the reduction potential of the free heme indicates that the interaction between the iron center and the lowest energy * orbital of 4CNPy must be similar in all cases. Thus, observation of the MLCT transition of 4CNPy-bound P450s provides a convenient route by which heme reduction potentials can be accurately estimated for a series of active site mutants of a single P450. The data presented here act as a calibration chart, against which reduction potentials of subsequent P450 BM3 point mutations can be estimated. The relationship shown in Fig. 6B (E MLCT ϭ (3.53 ϫ E m ) ϩ 17,005 cm Ϫ1 ) allows the evaluation of a P450 heme reduction potential, simply by knowing the energy of the MLCT absorption of the P450 red -4CNPy adduct.
CONCLUSION
The ligand 4-cyanopyridine exhibits a strong preference for ferrous heme and produces a P450 red -4CNPy adduct with very unusual spectral properties. These observations have led us to develop an extremely convenient method for the determination of K d values for substrate binding to reduced P450s. In addition, an analysis of the correlation between P450 reduction potentials and the energy of the MLCT bands seen for P450 red4CNPy adducts opens up a novel method for the prediction of reduction potentials for P450 BM3 and even perhaps for hemethiolate proteins in general (e.g. chloroperoxidase and nitricoxide synthase). 
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